EDGAR Filing Documents for 0000950170-23-008141

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:

SEC Accession No. 0000950170-23-008141

Filing Date

2023-03-15

Accepted

2023-03-15 16:13:42

Documents

164

Period of Report

2022-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	20-F	lmnl-20221231.htm iXBRL	20-F	9641635
2	EX-2.1	lmnl-ex2_1.htm	EX-2	165450
3	EX-8.1	lmnl-ex8_1.htm	EX-8	13928
4	EX-12.1	lmnl-ex12_1.htm	EX-12	24237
5	EX-12.2	lmnl-ex12_2.htm	EX-12	24514
6	EX-13.1	lmnl-ex13_1.htm	EX-13	14267
7	EX-13.2	lmnl-ex13_2.htm	EX-13	13591
8	EX-15.1	lmnl-ex15_1.htm	EX-15	10588
9	GRAPHIC	img120098058_0.jpg	GRAPHIC	3557
10	GRAPHIC	img209846603_0.jpg	GRAPHIC	208271
11	GRAPHIC	img209846603_1.jpg	GRAPHIC	196470
12	GRAPHIC	img209846603_2.jpg	GRAPHIC	272559
13	GRAPHIC	img209846603_3.jpg	GRAPHIC	207714
14	GRAPHIC	img209846603_4.jpg	GRAPHIC	110514
15	GRAPHIC	img209846603_5.jpg	GRAPHIC	2419
16	GRAPHIC	img209846603_6.jpg	GRAPHIC	6104
	Complete submission text file	0000950170-23-008141.txt		36395118

Data Files

Seq	Description	Document	Type	Size
17	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT	lmnl-20221231_pre.xml	EX-101.PRE	895177
18	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT	lmnl-20221231_cal.xml	EX-101.CAL	141064
19	XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT	lmnl-20221231_lab.xml	EX-101.LAB	1081139
20	XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT	lmnl-20221231.xsd	EX-101.SCH	213051
21	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT	lmnl-20221231_def.xml	EX-101.DEF	595116
158	EXTRACTED XBRL INSTANCE DOCUMENT	lmnl-20221231_htm.xml	XML	8717905

Mailing Address 440 ARMAND-FRAPPIER BLVD. SUITE 300 LAVAL A8 H7V 4B4

Business Address 231 DUNDAS STREET EAST BELLEVILLE A6 K8N 1E2 450-781-0115

Liminal BioSciences Inc. (Filer) CIK: 0001351172 (see all company filings)